Page 120 - 《中国药科大学学报》2025年第5期

652 学报 Journal of China Pharmaceutical University 2025, 56(5): 645 − 653 第 56 卷

挥重要作用，不仅是 CVDs 的致病因素，也是潜在 [16] Wang PC, Konja D, Singh S, et al. Endothelial senescence:
的治疗靶点。未来的研究和治疗策略有望通过靶 from macro- to micro-vasculature and its implications on car-
diovascular health[J]. Int J Mol Sci, 2024, 25(4): 1978.
向 ECs 衰老，改善血管功能障碍，延缓 CVDs 的发 [17] Suda M, Paul KH, Minamino T, et al. Senescent cells: a thera-
展，改善其预后。中药在 ECs 衰老的过程中展现出 peutic target in cardiovascular diseases[J]. Cells, 2023, 12(9):
全方位，多靶点、多机制的优势，为中医药治疗衰老 1296.
[18] Li H, Yang Z, Liang W, et al. DHCR24 insufficiency promotes
提供新方法与新思路。 vascular endothelial cell senescence and endothelial dysfunc-
tion via inhibition of caveolin-1/ERK signaling[J]. J Gerontol A
Biol Sci Med Sci, 2024, 79(4): glae059.
References
[19] Li J, Zhang J, Yu PC, et al. ROS-responsive & scavenging NO
[1] López-Otín C, Blasco MA, Partridge L, et al. Hallmarks of ag- nanomedicine for vascular diseases treatment by inhibiting en-
ing: an expanding universe[J]. Cell, 2023, 186(2): 243-278. doplasmic reticulum stress and improving NO bioavailability[J].
[2] Chmielewski PP, Data K, Strzelec B, et al. Human aging and Bioact Mater, 2024, 37: 239-252.
age-related diseases: from underlying mechanisms to pro- [20] Aguilar VM, Paul A, Lazarko D, et al. Paradigms of endothe-
longevity interventions[J]. Aging Dis, 2024, 16(4): 1853-1877. lial stiffening in cardiovascular disease and vascular aging[J].
[3] Hayflick L, Moorhead PS. The serial cultivation of human Front Physiol, 2023, 13: 1081119.
diploid cell strains[J]. Exp Cell Res, 1961, 25: 585-621. [21] Wang XW, Guo ZK, Ding ZF, et al. Endothelin-1 upregulation
[4] Zhang L, Pitcher LE, Yousefzadeh MJ, et al. Cellular senes- mediates aging-related cardiac fibrosis[J]. J Mol Cell Cardiol,
cence: a key therapeutic target in aging and diseases[J]. J Clin 2015, 80: 101-109.
Invest, 2022, 132(15): e158450. [22] Xu SW, Ilyas I, Little PJ, et al. Endothelial dysfunction in
[5] Augustin HG, Koh GY. A systems view of the vascular en- atherosclerotic cardiovascular diseases and beyond: from mech-
dothelium in health and disease[J]. Cell, 2024, 187(18): 4833- anism to pharmacotherapies[J]. Pharmacol Rev, 2021, 73(3):
4858. 924-967.
[6] Bloom SI, Islam MT, Lesniewski LA, et al. Mechanisms and [23] Bu LL, Yuan HH, Xie LL, et al. New dawn for atherosclerosis:
consequences of endothelial cell senescence[J]. Nat Rev Cardi- vascular endothelial cell senescence and death[J]. Int J Mol Sci,
ol, 2023, 20(1): 38-51. 2023, 24(20): 15160.
[7] Bloom SI, Liu Y, Tucker JR, et al. Endothelial cell telomere [24] Bian WH, Jing XH, Yang ZY, et al. Downregulation of LncR-
dysfunction induces senescence and results in vascular and NA NORAD promotes Ox-LDL-induced vascular endothelial
metabolic impairments[J]. Aging Cell, 2023, 22(8): e13875. cell injury and atherosclerosis[J]. Aging (Albany NY), 2020,
[8] Ferrari S, Pesce M. Stiffness and aging in cardiovascular dis- 12(7): 6385-6400.
eases: the dangerous relationship between force and [25] Huang X, Zhou Y, Guo YK, et al. Selenium-doped copper for-
senescence[J]. Int J Mol Sci, 2021, 22(7): 3404. mate nanozymes with antisenescence and oxidative stress reduc-
[9] Ya JY, Whitby A, Bayraktutan U. Metabolites and metabolic tion for atherosclerosis treatment[J]. Nano Lett, 2025, 25(7):
functional changes-potential markers for endothelial cell senes- 2662-2669.
cence[J]. Biomolecules, 2024, 14(11): 1476. [26] Liu MM, Wang DN, Qi CY, et al. Brain ischemia causes sys-
[10] Stabenow LK, Zibrova D, Ender C, et al. Oxidative glucose temic Notch1 activity in endothelial cells to drive atherosclero-
metabolism promotes senescence in vascular endothelial sis[J]. Immunity, 2024, 57(9): 2157-2172. e7.
cells[J]. Cells, 2022, 11(14): 2213. [27] Clayton ZS, Rossman MJ, Mahoney SA, et al. Cellular senes-
[11] Wiley CD, Campisi J. The metabolic roots of senescence: mech- cence contributes to large elastic artery stiffening and endothe-
anisms and opportunities for intervention[J]. Nat Metab, 2021, lial dysfunction with aging: amelioration with senolytic treat-
3(10): 1290-1301. ment[J]. Hypertension, 2023, 80(10): 2072-2087.
[12] Song XX, Yang BY, Qiu FY, et al. High glucose and free fatty [28] Xiang QY, Tian F, Xu J, et al. New insight into dyslipidemia-
acids induce endothelial progenitor cell senescence via PGC- induced cellular senescence in atherosclerosis[J]. Biol Rev
1α/SIRT1 signaling pathway[J]. Cell Biol Int, 2017, 41(10): Camb Philos Soc, 2022, 97(5): 1844-1867.
1146-1159. [29] Russo I, Frangogiannis NG. Diabetes-associated cardiac fibro-
[13] Hwang HJ, Kim N, Herman AB, et al. Factors and pathways sis: cellular effectors, molecular mechanisms and therapeutic
modulating endothelial cell senescence in vascular aging[J]. Int opportunities[J]. J Mol Cell Cardiol, 2016, 90: 84-93.
J Mol Sci, 2022, 23(17): 10135. [30] Tang XQ, Li PH, Chen HZ. Cardiomyocyte senescence and cel-
[14] Chen MS, Lee RT, Garbern JC. Senescence mechanisms and lular communications within myocardial microenvironments[J].
targets in the heart[J]. Cardiovasc Res, 2022, 118(5): 1173- Front Endocrinol (Lausanne), 2020, 11: 280.
1187. [31] Luan Y, Zhu XF, Jiao YX, et al. Cardiac cell senescence:
[15] Vakka A, Warren JS, Drosatos K. Cardiovascular aging: from molecular mechanisms, key proteins and therapeutic targets[J].
cellular and molecular changes to therapeutic interventions[J]. J Cell Death Discov, 2024, 10(1): 78.
Cardiovasc Aging, 2023, 3(3): 23. [32] Qian M, Li S, Xi K, et al. ECM-engineered electrospun fibers